We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01374100
Recruitment Status : Terminated (Slow accrual, and revised power calculation for primary end-points)
First Posted : June 15, 2011
Last Update Posted : September 19, 2016
Jewish General Hospital
Information provided by (Responsible Party):
Thomas Jagoe, McGill University

April 13, 2011
June 15, 2011
September 19, 2016
February 2009
May 2011   (Final data collection date for primary outcome measure)
  • Change in Depression and Anxiety [ Time Frame: 6 weeks ]
    Depression and anxiety will be measured using the Hospital Anxiety Depression Scale (HADS); The HADS is a 14-item self-rated questionnaire, consisting of two 7-item subscales. It was developed to identify anxiety and depression in non-psychiatric medical outpatients. Each item on the HADS is scored from 0 (no problem) to 3 (maximum distress). The HADS will be administered within 2 weeks of completing each exercise program.
  • Change in Quality of Life (QoL) [ Time Frame: 6 weeks ]
    The general version of the Functional Assessment of Cancer Therapy scale (FACT-G) will be used to measure Quality of Life (QoL) after completion of each 6 week exercise program. This questionnaire consists of 4 subscales: Physical well-being (PWB), Social well-being (SWB), Emotional well-being (EWB) and Functional well-being (FWB). A change of 4 points on the total FACT score is regarded as clinically significant.
Same as current
Complete list of historical versions of study NCT01374100 on ClinicalTrials.gov Archive Site
  • Change in functional capacity [ Time Frame: 6 weeks ]
    Functional capcity will be measured using the Simmonds Functional Assessment (SFA) within 2 weeks of finishing each 6-week exercise program. This tool consists of eight items: putting on a sock, tying a belt, putting coins in a cup, reaching forward, repeated reach up (3 times), repeated sit to stand (2 times), speed walk for 50 feet, and walking for 6 minutes. Patient satisfaction will be measured by asking all participants to answer a two item questionnaire with a 10-point visual analog scale response option.
  • Change in cancer Symptoms [ Time Frame: 6 weeks ]
    Symptoms commonly reported by lung and GI cancer patients will be measured using the Edmonton Symptom Assessment Scale (ESAS). The ESAS is a 12-item patient rated symptom questionnaire scored using a 10-point visual analogue scale. The ESAS will be administered within 2 weeks of completing each 6-week exercise program.
  • Program Satisfaction [ Time Frame: 6 weeks ]
    Patient satisfaction will be measured by asking all participants to answer a two-item questionnaire after they have completed each 6-week exercise program.
Same as current
Not Provided
Not Provided
Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy
Effect of Qigong Therapy in Patients With Advanced NSCLC and GI Cancer Undergoing Chemotherapy
Cancer patients face a number of symptoms related to treatment or disease which may impair quality of life, such as decreased functional capacity, fatigue, nausea an vomiting, distress, depression and unmet psychological needs. Due to this array of symptoms, cancer patients often seek supportive complementary and alternative medicine, which many patients use along with conventional treatments. Qigong, a type traditional chinese medicine, is a mind-body exercise that combines meditation, slow physical movements, and controlled breathing. The investigators hypothesise that Qigong therapy is better in the reduction of anxiety and depression levels and the improvement of quality of life in patients with lung and gastrointestinal (GI) cancer who are eligible for anti-cancer treatment, when compared to standard exercise training.
As per summary above
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Supportive Care
  • Carcinoma, Non-Small-Cell Lung
  • Cancer of the Gastrointestinal Tract
  • Behavioral: Standard Exercise
    The standard exercise therapy program will include 12 treatments of approximately 45 minutes duration, twice a week for a period of six weeks by the same instructor and at the same location as for Qigong therapy. This exercise program is supervised and consists of cardio-vascular and resistance training exercises. Participants are asked to refrain from practicing Qigong during this 6 week period.
  • Behavioral: Qigong Exercise
    Qigong therapy will be led by a trained Qigong instructor and will occur for 45 minutes sessions, twice a week for a period of six weeks. Qigong is a self-directed walking exercise program that involves arm movements that are coordinated with slight movements of the waist, while in a state of deep relaxation or meditation. Patients will be asked to refrain from independent resistance or cardiovascular training during this 6 week period.
  • Active Comparator: Standard Exercise
    See methods below - standard strength and endurance training
    • Behavioral: Standard Exercise
    • Behavioral: Qigong Exercise
  • Experimental: Qigong exercise
    See methods below - medical QiGong therapy session
    • Behavioral: Standard Exercise
    • Behavioral: Qigong Exercise
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
May 2011
May 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. A pathologically (histological or cytological) confirmed clinical diagnosis of non-small cell lung cancer (NSCLC) or GI cancer
  2. Stage 3 or 4 disease and eligible for anti-cancer treatment
  3. Performance status (PS) of 0 - 2 as determined by the Eastern Cooperative Oncology Group-Performance Status
  4. Life expectancy estimated at > 4 months
  5. Age 18 years or older
  6. Willing and able to provide informed consent
  7. Must be approved for participation by the oncology treatment team
  8. Able to communicate in French or English

Exclusion Criteria:

  1. Contraindication to exercise as determined by the oncology treatment team
  2. Severe cardiac or neuro-muscular/skeletal disease
  3. Engaging in interventions to address anxiety or depressive symptoms
  4. Brain metastases
  5. Active psychiatric conditions
  6. Pregnant or breast-feeding mothers
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Plan to Share IPD: Yes
Plan Description: Peer-reviewed manuscripts and conference proceedings
Thomas Jagoe, McGill University
McGill University
Jewish General Hospital
Principal Investigator: Thomas Jagoe, MD, PhD McGill, Cancer Nutrition Rehabilitation Program
McGill University
September 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP